POLYMORPHS OF A GABAA α5 AGONIST AND METHODS OF USING IN THE TREATMENT OF COGNITIVE IMPAIRMENT

Title:

POLYMORPHS OF A GABAA α5 AGONIST AND METHODS OF USING IN THE TREATMENT OF COGNITIVE IMPAIRMENT

Document Type and Number:

WIPO Patent Application WO/2022/011314

Kind Code:

A8

Abstract:

Crystalline forms of a GABAA α5 agonist, pharmaceutical compositions and combinations comprising those crystalline forms, their use in methods of treating cognitive impairment associated with central nervous system (CNS) disorders, cognitive impairment associated with brain cancer, the brain cancer itself or Parkinson's disease psychosis and methods of producing the crystalline forms.

More Like This:

JPS5283891	HETEROCYCLIC COMPOUNDS
JPS62142179	PRODUCTION OF MITOMYCIN DERIVATIVE
WO/2007/106144	NOR-SECO-, BIS-NOR-SECO, TRIS-NOR-SECO- AND HIGHER NOR-SECO- CUCURBIT[n]URIL COMPOUNDS

Inventors:

GANDLA DEEPA (US)
GREGG BRIAN (US)
HEGDE VISHNUMURTHY (US)
PARENT STEPHAN (US)
HOUSTON TRAVIS (US)

Application Number:

PCT/US2021/041179

Publication Date:

February 09, 2023

Filing Date:

July 09, 2021

Export Citation:

Click for automatic bibliography generation Help

Assignee:

AGENEBIO INC (US)

International Classes:

C07D487/14; A61K45/06; A61P25/00; A61P25/16; A61P25/18; A61P25/28; A61P35/00

Attorney, Agent or Firm:

HALEY, James, F., Jr. et al. (US)

Download PDF:

View/Download PDF PDF Help

Previous Patent: MODIFICATION OF METALLIC SURFACES WITH PHOSPHONIC ACIDS

Next Patent: ION CURRENT DROOP COMPENSATION